Literature DB >> 31348890

A Paranigral VTA Nociceptin Circuit that Constrains Motivation for Reward.

Kyle E Parker1, Christian E Pedersen2, Adrian M Gomez1, Skylar M Spangler3, Marie C Walicki1, Shelley Y Feng1, Sarah L Stewart1, James M Otis4, Ream Al-Hasani5, Jordan G McCall5, Kristina Sakers6, Dionnet L Bhatti1, Bryan A Copits1, Robert W Gereau1, Thomas Jhou7, Thomas J Kash8, Joseph D Dougherty6, Garret D Stuber9, Michael R Bruchas10.   

Abstract

Nociceptin and its receptor are widely distributed throughout the brain in regions associated with reward behavior, yet how and when they act is unknown. Here, we dissected the role of a nociceptin peptide circuit in reward seeking. We generated a prepronociceptin (Pnoc)-Cre mouse line that revealed a unique subpopulation of paranigral ventral tegmental area (pnVTA) neurons enriched in prepronociceptin. Fiber photometry recordings during progressive ratio operant behavior revealed pnVTAPnoc neurons become most active when mice stop seeking natural rewards. Selective pnVTAPnoc neuron ablation, inhibition, and conditional VTA nociceptin receptor (NOPR) deletion increased operant responding, revealing that the pnVTAPnoc nucleus and VTA NOPR signaling are necessary for regulating reward motivation. Additionally, optogenetic and chemogenetic activation of this pnVTAPnoc nucleus caused avoidance and decreased motivation for rewards. These findings provide insight into neuromodulatory circuits that regulate motivated behaviors through identification of a previously unknown neuropeptide-containing pnVTA nucleus that limits motivation for rewards.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NOPR; motivation; neuropeptide; nociceptin; opioid; optogenetics; orphanin FQ; photometry; reward; ventral tegmental area

Mesh:

Substances:

Year:  2019        PMID: 31348890      PMCID: PMC7001890          DOI: 10.1016/j.cell.2019.06.034

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  69 in total

1.  Whole-brain mapping of direct inputs to midbrain dopamine neurons.

Authors:  Mitsuko Watabe-Uchida; Lisa Zhu; Sachie K Ogawa; Archana Vamanrao; Naoshige Uchida
Journal:  Neuron       Date:  2012-06-07       Impact factor: 17.173

2.  Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats.

Authors:  Roberto Ciccocioppo; Carlo Polidori; Lorena Antonelli; Severo Salvadori; Remo Guerrini; Maurizio Massi
Journal:  Peptides       Date:  2002-01       Impact factor: 3.750

3.  Activation of VTA GABA neurons disrupts reward consumption.

Authors:  Ruud van Zessen; Jana L Phillips; Evgeny A Budygin; Garret D Stuber
Journal:  Neuron       Date:  2012-03-21       Impact factor: 17.173

Review 4.  Neurotensin and dopamine interactions.

Authors:  E B Binder; B Kinkead; M J Owens; C B Nemeroff
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 25.468

Review 5.  Reward, dopamine and the control of food intake: implications for obesity.

Authors:  Nora D Volkow; Gene-Jack Wang; Ruben D Baler
Journal:  Trends Cogn Sci       Date:  2010-11-24       Impact factor: 20.229

Review 6.  Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis.

Authors:  Paul W Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-09       Impact factor: 12.779

7.  Orphanin FQ/nociceptin blocks methamphetamine place preference in rats.

Authors:  Rong-Jie Zhao; Ran-Sook Woo; Min-Suk Jeong; Byoung-Soo Shin; Dong-Goo Kim; Kee-Won Kim
Journal:  Neuroreport       Date:  2003-12-19       Impact factor: 1.837

8.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain.

Authors:  Linda Madisen; Theresa A Zwingman; Susan M Sunkin; Seung Wook Oh; Hatim A Zariwala; Hong Gu; Lydia L Ng; Richard D Palmiter; Michael J Hawrylycz; Allan R Jones; Ed S Lein; Hongkui Zeng
Journal:  Nat Neurosci       Date:  2009-12-20       Impact factor: 24.884

9.  The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses.

Authors:  Thomas C Jhou; Howard L Fields; Mark G Baxter; Clifford B Saper; Peter C Holland
Journal:  Neuron       Date:  2009-03-12       Impact factor: 17.173

Review 10.  Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more.

Authors:  T Darland; M M Heinricher; D K Grandy
Journal:  Trends Neurosci       Date:  1998-05       Impact factor: 13.837

View more
  21 in total

Review 1.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

Review 2.  Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions.

Authors:  Lloyd D Fricker; Elyssa B Margolis; Ivone Gomes; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2020-06-02       Impact factor: 4.436

3.  Dopamine signaling in the nucleus accumbens core mediates latent inhibition.

Authors:  Munir Gunes Kutlu; Jennifer E Zachry; Patrick R Melugin; Jennifer Tat; Stephanie Cajigas; Atagun U Isiktas; Dev D Patel; Cody A Siciliano; Geoffrey Schoenbaum; Melissa J Sharpe; Erin S Calipari
Journal:  Nat Neurosci       Date:  2022-07-28       Impact factor: 28.771

Review 4.  The rostromedial tegmental (RMTg) "brake" on dopamine and behavior: A decade of progress but also much unfinished work.

Authors:  Thomas C Jhou
Journal:  Neuropharmacology       Date:  2021-08-22       Impact factor: 5.273

5.  Parabrachial opioidergic projections to preoptic hypothalamus mediate behavioral and physiological thermal defenses.

Authors:  Aaron J Norris; Jordan R Shaker; Aaron L Cone; Imeh B Ndiokho; Michael R Bruchas
Journal:  Elife       Date:  2021-03-05       Impact factor: 8.140

6.  Ventral tegmental area GABAergic inhibition of cholinergic interneurons in the ventral nucleus accumbens shell promotes reward reinforcement.

Authors:  Ream Al-Hasani; Raajaram Gowrishankar; Gavin P Schmitz; Christian E Pedersen; David J Marcus; Sofia E Shirley; Taylor E Hobbs; Abigail J Elerding; Sophie J Renaud; Miao Jing; Yulong Li; Veronica A Alvarez; Julia C Lemos; Michael R Bruchas
Journal:  Nat Neurosci       Date:  2021-08-12       Impact factor: 28.771

7.  Dopamine release in the nucleus accumbens core signals perceived saliency.

Authors:  Munir Gunes Kutlu; Jennifer E Zachry; Patrick R Melugin; Stephanie A Cajigas; Maxime F Chevee; Shannon J Kelly; Banu Kutlu; Lin Tian; Cody A Siciliano; Erin S Calipari
Journal:  Curr Biol       Date:  2021-09-15       Impact factor: 10.900

8.  A photoswitchable GPCR-based opsin for presynaptic inhibition.

Authors:  Bryan A Copits; Raaj Gowrishankar; Patrick R O'Neill; Jun-Nan Li; Kasey S Girven; Judy J Yoo; Xenia Meshik; Kyle E Parker; Skylar M Spangler; Abigail J Elerding; Bobbie J Brown; Sofia E Shirley; Kelly K L Ma; Alexis M Vasquez; M Christine Stander; Vani Kalyanaraman; Sherri K Vogt; Vijay K Samineni; Tommaso Patriarchi; Lin Tian; N Gautam; Roger K Sunahara; Robert W Gereau; Michael R Bruchas
Journal:  Neuron       Date:  2021-05-11       Impact factor: 18.688

Review 9.  The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies.

Authors:  Lawrence Toll; Andrea Cippitelli; Akihiko Ozawa
Journal:  CNS Drugs       Date:  2021-05-31       Impact factor: 6.497

10.  Prepronociceptin-Expressing Neurons in the Extended Amygdala Encode and Promote Rapid Arousal Responses to Motivationally Salient Stimuli.

Authors:  Jose Rodriguez-Romaguera; Randall L Ung; Hiroshi Nomura; James M Otis; Marcus L Basiri; Vijay M K Namboodiri; Xueqi Zhu; J Elliott Robinson; Hanna E van den Munkhof; Jenna A McHenry; Louisa E H Eckman; Oksana Kosyk; Thomas C Jhou; Thomas L Kash; Michael R Bruchas; Garret D Stuber
Journal:  Cell Rep       Date:  2020-11-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.